Elvir SAS   Report issue

For profit Phase 2
Founded: Conde Sur Vire France (1962)
Status: Left NME R&D (2018)

Organization Overview

First Clinical Trial
2008
NCT00663221
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (3)

calcium (1 trial)

vitamin d3 (1 trial)

vitis vinifera (1 trial)

Drugs in Other Trials (4)

cyanocobalamin (berocca) (1 trial)

folic acid (1 trial)

l-epigallocatechin (1 trial)

pyridoxine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Osteoporosis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 7